Identification of β1 integrin as mediator of melanoma cell adhesion to lumican

Biochemical and Biophysical Research Communications

Volumn 365, Issue 2, 2008, Pages 266-272

  D'Onofrio, Marie France ^a   Brézillon, Stéphane ^a   Baranek, Thomas ^b   Perreau, Corinne ^a   Roughley, Peter J ^c   Maquart, François Xavier ^a   Wegrowski, Yanusz ^a  

^a CNRS   (France)

^b EA 3796   (France)

^c SHRINERS HOSPITAL FOR CHILDREN   (Canada)

Author keywords

Adhesion; Integrin; Lumican; Melanoma; Migration; Proteoglycans; Rhodocetin

Indexed keywords

ALPHA2 INTEGRIN; BETA1 INTEGRIN; DIVALENT CATION; LUMICAN; MAGNESIUM; MANGANESE; MONOCLONAL ANTIBODY; PROTEIN SUBUNIT; RHODOCETIN; UNCLASSIFIED DRUG; KERATAN SULFATE; PROTEOCHONDROITIN SULFATE;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; ANIMAL; CELL MOTION; DRUG EFFECT; MELANOMA; METABOLISM; MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD29; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KERATAN SULFATE; MELANOMA; MICE; PROTEOCHONDROITIN SULFATES;

EID: 36349010640     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.155     Document Type: Article

References (25)

1. Iozzo R.V. Matrix proteoglycans: from molecular design to cellular function. Annu. Rev. Biochem. 67 (1998) 609-652
2. Chakravarti S., Magnuson T., Lass J.H., Jepsen K.J., LaMantia C., and Carroll H. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J. Cell Biol. 141 (1998) 1277-1286
3. Vuillermoz B., Wegrowski Y., L Contet-Audonneau J., Danoux L., Pauly G., and Maquart F.X. Influence of aging on glycosaminoglycans and small leucine-rich proteoglycans production by skin fibroblasts. Mol. Cell Biochem. 277 (2005) 63-72
4. Vuillermoz B., Khoruzhenko A., D'Onofrio M.F., Ramont L., Venteo L., Perreau C., Antonicelli F., Maquart F.X., and Wegrowski Y. The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp. Cell Res. 296 (2004) 294-306
5. Leygue E., Snell L., Dotzlaw H., Troup S., Hiller-Hitchcock T., Murphy L.C., Roughley P.J., and Watson P.H. Lumican and decorin are differentially expressed in human breast carcinoma. J. Pathol. 192 (2000) 313-320
6. Troup S., Njue C., Kliewer E.V., Parisien M., Roskelley C., Chakravarti S., Roughley P.J., Murphy L.C., and Watson P.H. Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin. Cancer Res. 9 (2003) 207-214
7. Hornebeck W., Emonard H., Monboisse J.C., and Bellon G. Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin. Cancer Biol. 12 (2002) 231-241
8. Parise L.V., Lee J., and Juliano R.L. New aspects of integrin signaling in cancer. Semin. Cancer Biol. 10 (2000) 407-414
9. Tsuji T., Kawada Y., Kai-Murozono M., Komatsu S., Han S.A., Takeuchi K., Mizushima H., Miyazaki K., and Irimura T. Regulation of melanoma cell migration and invasion by laminin-5 and alpha3beta1 integrin (VLA-3). Clin. Exp. Metastasis 19 (2002) 127-134
10. Felding-Habermann B., Fransvea E., O'Toole T.E., Manzuk L., Faha B., and Hensler M. Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells. Clin. Exp. Metastasis 19 (2002) 427-436
11. Ramos D.M., Berston E.D., and Kramer R.H. Analysis of integrin receptors for laminin and type IV collagen on metastatic B16 melanoma cells. Cancer Res. 50 (1990) 728-734
12. Hart I.R., Birch M., and Marshall J.F. Cell adhesion receptor expression during melanoma progression and metastasis. Cancer Metastasis 10 (1991) 115-128
13. Piez K.A., Eigner E.A., and Lewis M.S. The chromatographic separation and amino acid composition of the subunits of several Collagens. Biochemistry 2 (1963) 58-66
14. Zhao W., Liu H., Xu S., Entschladen F., Niggemann B., Zanker K.S., and Han R. Migration and metalloproteinases determine the invasive potential of mouse melanoma cells, but not melanin and telomerase. Cancer Lett. 162 (2001) S49-S55
15. Makihira S., Yan W., Ohno S., Kawamoto T., Fujimoto K., Okimura A., Yoshida E., Noshiro M., Hamada T., and Kato Y. Enhancement of cell adhesion and spreading by a cartilage-specific noncollagenous protein, cartilage matrix protein (CMP/Matrilin-1), via integrin alpha1beta1. J. Biol. Chem. 274 (1999) 11417-11423
16. Garnotel R., Rittie L., Poitevin S., Monboisse J.C., Nguyen P., Potron G., Maquart F.X., Randoux A., and Gillery P. Human blood monocytes interact with type I collagen through alpha x beta 2 integrin (CD11c-CD18, gp150-95). J. Immunol. 164 (2000) 5928-5934
17. Wang H., Ng T.B., Ooi V.E., and Liu W.K. Effects of lectins with different carbohydrate-binding specificities on hepatoma, choriocarcinoma, melanoma and osteosarcoma cell lines. Int. J. Biochem. Cell Biol. 32 (2000) 365-372
18. Humtsoe J.O., Feng S., Thakker G.D., Yang J., Hong J., and Wary K.K. Regulation of cell-cell interactions by phosphatidic acid phosphatase 2b/VCIP. EMBO J. 22 (2003) 1539-1554
19. Eble J.A., and Tuckwell D.S. The alpha2beta1 integrin inhibitor rhodocetin binds to the A-domain of the integrin alpha2 subunit proximal to the collagen-binding site. Biochem. J. 376 (2003) 77-85
20. Eble J.A., Beermann B., Hinz H.J., and Schmidt-Hederich A. alpha2beta1 integrin is not recognized by rhodocytin but is the specific, high affinity target of rhodocetin, an RGD-independent disintegrin and potent inhibitor of cell adhesion to collagen. J. Biol. Chem. 276 (2001) 12274-12284
21. Knorr R., and Dustin M.L. The lymphocyte function-associated antigen 1 I domain is a transient binding module for intercellular adhesion molecule (ICAM)-1 and ICAM-3 in hydrodynamic flow. J. Exp. Med. 186 (1997) 719-730
22. Shimaoka M., Takagi J., and Springer T.A. Conformational regulation of integrin structure and function. Annu. Rev. Biophys. Biomol. Struct. 31 (2002) 485-516
23. Kim J.K., Xu Y., Xu X., Keene D.R., Gurusiddappa S., Liang X., Wary K.K., and Hook M. A novel binding site in collagen type III for integrins alpha1beta1 and alpha2beta1. J. Biol. Chem. 280 (2005) 32512-32520
24. Santoro S.A. Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Cell 46 (1986) 913-920
25. Guidetti G., Bertoni A., Viola M., Tira E., Balduini C., and Torti M. The small proteoglycan decorin supports adhesion and activation of human platelets. Blood 100 (2002) 1707-1714